Company profile DNTH

Dianthus Therapeutics Inc
magenta therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. by creating a platform focused on key areas of transplant medicine, magenta therapeutics is pioneering an integrated, but modular approach to stem cell therapies that reboot the blood and immune ...systems to create patient benefit. founded by internationally recognized leaders in stem cell transplant medicine, magenta therapeutics was launched in 2016 by third rock ventures and atlas venture and is headquartered in cambridge, mass. for more information, please visit www.magentatx.com. Show More
Quarter analysis & expected interestLast update: February 09 2024 10:21:05.

After 39 days of this quarter the interest is at 200.0. Based on that we can calculate that during remaining 52 days it will total up to 467.0.
dianthus therapeutics expected interest is significantly higher compared to previous quarter (+88.3%) and same quarter last year (+678.3%).

YearQ1Q2Q3Q4
20190
161
inf% QoQ
40
-75.2% QoQ
94
135.0% QoQ
2020 89
inf% YoY -5.3% QoQ
68
-57.8% YoY -23.6% QoQ
54
35.0% YoY -20.6% QoQ
39
-58.5% YoY -27.8% QoQ
2021 119
33.7% YoY 205.1% QoQ
144
111.8% YoY 21.0% QoQ
168
211.1% YoY 16.7% QoQ
157
302.6% YoY -6.5% QoQ
2022 346
190.8% YoY 120.4% QoQ
262
81.9% YoY -24.3% QoQ
116
-31.0% YoY -55.7% QoQ
188
19.7% YoY 62.1% QoQ
2023 60
-82.7% YoY -68.1% QoQ
203
-22.5% YoY 238.3% QoQ
205
76.7% YoY 1.0% QoQ
248
31.9% YoY 21.0% QoQ
2024 200
233.3% YoY -19.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and dianthus therapeutics search interest

There is not enough data for dianthus therapeutics to provide correlation calculation

Analysis of YoY 5Y Google Trends Last update: February 09 2024 10:21:07.

The average 5 years interest of dianthus therapeutics was 11.34 per week.
The last year interest of dianthus therapeutics compared to the last 5 years has changed by 55.38%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 210.76%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DNTH103 phase 1 clinical trials to provide analysis

Correlation between past revenue and DNTH103 phase 1 clinical trials search interest

There is not enough data for DNTH103 phase 1 clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DNTH103 phase 1 clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 10:21:12.

After 39 days of this quarter the interest is at 84.0. Based on that we can calculate that during remaining 52 days it will total up to 196.0.
severe autoimmune diseases expected interest is significantly higher compared to previous quarter (+71.9%) and same quarter last year (+211.1%).

YearQ1Q2Q3Q4
201940
94
135.0% QoQ
245
160.6% QoQ
109
-55.5% QoQ
2020 85
112.5% YoY -22.0% QoQ
77
-18.1% YoY -9.4% QoQ
141
-42.4% YoY 83.1% QoQ
110
0.9% YoY -22.0% QoQ
2021 41
-51.8% YoY -62.7% QoQ
32
-58.4% YoY -22.0% QoQ
96
-31.9% YoY 200.0% QoQ
147
33.6% YoY 53.1% QoQ
2022 175
326.8% YoY 19.0% QoQ
174
443.8% YoY -0.6% QoQ
94
-2.1% YoY -46.0% QoQ
112
-23.8% YoY 19.1% QoQ
2023 63
-64.0% YoY -43.8% QoQ
118
-32.2% YoY 87.3% QoQ
94
0.0% YoY -20.3% QoQ
114
1.8% YoY 21.3% QoQ
2024 84
33.3% YoY -26.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and severe autoimmune diseases search interest

There is not enough data for severe autoimmune diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends Last update: February 09 2024 10:21:13.

The average 5 years interest of severe autoimmune diseases was 8.6 per week.
The last year interest of severe autoimmune diseases compared to the last 5 years has changed by -0.23%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -17.97%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 15:36:32.

After 39 days of this quarter the interest is at 185.0. Based on that we can calculate that during remaining 52 days it will total up to 432.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019285
394
38.2% QoQ
326
-17.3% QoQ
321
-1.5% QoQ
2020 354
24.2% YoY 10.3% QoQ
413
4.8% YoY 16.7% QoQ
378
16.0% YoY -8.5% QoQ
362
12.8% YoY -4.2% QoQ
2021 375
5.9% YoY 3.6% QoQ
373
-9.7% YoY -0.5% QoQ
347
-8.2% YoY -7.0% QoQ
328
-9.4% YoY -5.5% QoQ
2022 452
20.5% YoY 37.8% QoQ
436
16.9% YoY -3.5% QoQ
363
4.6% YoY -16.7% QoQ
504
53.7% YoY 38.8% QoQ
2023 449
-0.7% YoY -10.9% QoQ
482
10.6% YoY 7.3% QoQ
440
21.2% YoY -8.7% QoQ
493
-2.2% YoY 12.0% QoQ
2024 185
-58.8% YoY -62.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and inflammatory diseases search interestLast update: February 09 2024 15:36:32.
Correlation coefficient between keyword and revenue is -0.11
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 15:36:34.

The average 5 years interest of inflammatory diseases was 30.88 per week.
The last year interest of inflammatory diseases compared to the last 5 years has changed by 15.97%.
The interest for inflammatory diseases is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 27.3%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 10:21:19.

After 39 days of this quarter the interest is at 265.0. Based on that we can calculate that during remaining 52 days it will total up to 618.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019426
581
36.4% QoQ
484
-16.7% QoQ
638
31.8% QoQ
2020 612
43.7% YoY -4.1% QoQ
552
-5.0% YoY -9.8% QoQ
588
21.5% YoY 6.5% QoQ
582
-8.8% YoY -1.0% QoQ
2021 630
2.9% YoY 8.2% QoQ
586
6.2% YoY -7.0% QoQ
680
15.6% YoY 16.0% QoQ
591
1.5% YoY -13.1% QoQ
2022 738
17.1% YoY 24.9% QoQ
802
36.9% YoY 8.7% QoQ
739
8.7% YoY -7.9% QoQ
709
20.0% YoY -4.1% QoQ
2023 799
8.3% YoY 12.7% QoQ
759
-5.4% YoY -5.0% QoQ
806
9.1% YoY 6.2% QoQ
878
23.8% YoY 8.9% QoQ
2024 265
-66.8% YoY -69.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and myasthenia gravis treatment search interest

There is not enough data for myasthenia gravis treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends Last update: February 09 2024 10:21:20.

The average 5 years interest of myasthenia gravis treatment was 51.51 per week.
The last year interest of myasthenia gravis treatment compared to the last 5 years has changed by 18.75%.
The interest for myasthenia gravis treatment is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 31.07%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for multifocal motor neuropathy treatment to provide analysis

Correlation between past revenue and multifocal motor neuropathy treatment search interest

There is not enough data for multifocal motor neuropathy treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for multifocal motor neuropathy treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for chronic inflammatory demyelinating polyneuropathy treatment to provide analysis

Correlation between past revenue and chronic inflammatory demyelinating polyneuropathy treatment search interest

There is not enough data for chronic inflammatory demyelinating polyneuropathy treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for chronic inflammatory demyelinating polyneuropathy treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 10:21:25.

After 39 days of this quarter the interest is at 56.0. Based on that we can calculate that during remaining 52 days it will total up to 131.0.
DNTH stock expected interest is significantly higher compared to same quarter last year (+627.8%) but similar to previous quarter.

YearQ1Q2Q3Q4
201997
36
-62.9% QoQ
158
338.9% QoQ
117
-25.9% QoQ
2020 94
-3.1% YoY -19.7% QoQ
52
44.4% YoY -44.7% QoQ
24
-84.8% YoY -53.8% QoQ
102
-12.8% YoY 325.0% QoQ
2021 27
-71.3% YoY -73.5% QoQ
58
11.5% YoY 114.8% QoQ
0
-100.0% YoY -100.0% QoQ
143
40.2% YoY inf% QoQ
2022 130
381.5% YoY -9.1% QoQ
248
327.6% YoY 90.8% QoQ
25
inf% YoY -89.9% QoQ
205
43.4% YoY 720.0% QoQ
2023 18
-86.2% YoY -91.2% QoQ
0
-100.0% YoY -100.0% QoQ
94
276.0% YoY inf% QoQ
154
-24.9% YoY 63.8% QoQ
2024 56
211.1% YoY -63.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and DNTH stock search interest

There is not enough data for DNTH stock to provide correlation calculation

Analysis of YoY 5Y Google Trends Last update: February 09 2024 10:21:26.

The average 5 years interest of DNTH stock was 7.04 per week.
The last year interest of DNTH stock compared to the last 5 years has changed by -12.07%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -29.74%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DNTH company to provide analysis

Correlation between past revenue and DNTH company search interest

There is not enough data for DNTH company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DNTH company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 20:15:07.

After 39 days of this quarter the interest is at 342.0. Based on that we can calculate that during remaining 52 days it will total up to 798.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019558
717
28.5% QoQ
632
-11.9% QoQ
681
7.8% QoQ
2020 882
58.1% YoY 29.5% QoQ
723
0.8% YoY -18.0% QoQ
710
12.3% YoY -1.8% QoQ
584
-14.2% YoY -17.7% QoQ
2021 760
-13.8% YoY 30.1% QoQ
626
-13.4% YoY -17.6% QoQ
561
-21.0% YoY -10.4% QoQ
564
-3.4% YoY 0.5% QoQ
2022 814
7.1% YoY 44.3% QoQ
813
29.9% YoY -0.1% QoQ
677
20.7% YoY -16.7% QoQ
697
23.6% YoY 3.0% QoQ
2023 891
9.5% YoY 27.8% QoQ
744
-8.5% YoY -16.5% QoQ
644
-4.9% YoY -13.4% QoQ
752
7.9% YoY 16.8% QoQ
2024 342
-61.6% YoY -54.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and biotechnology search interestLast update: February 09 2024 20:15:07.
Correlation coefficient between keyword and revenue is -0.44
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 20:15:09.

The average 5 years interest of biotechnology was 55.07 per week.
The last year interest of biotechnology compared to the last 5 years has changed by 3.36%.
The interest for biotechnology is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by 1.53%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for DNTH
Earnings date: 2024-03-21 After close
Company name: Dianthus Therapeutics Inc
Sector: Professional, Scientific, and Technical Services
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-06T12:45:14Z

Analyst Upgrades
Wedbush Maintains Outperform on Dianthus Therapeutics, Raises Price Target to $105

2026-05-06T02:57:21Z

GlobeNewswire
LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis

2026-05-05T20:01:00Z

GlobeNewswire
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results

2026-05-01T20:30:00Z

GlobeNewswire
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-04-09T16:34:36Z

Analyst Upgrades
Wolfe Research Initiates Coverage On Dianthus Therapeutics with Outperform Rating, Announces Price Target of $98

2026-04-06T20:01:00Z

GlobeNewswire
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-03-19T13:14:03Z

Analyst Upgrades
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

2026-03-19T13:03:45Z

Analyst Upgrades
Wells Fargo Initiates Coverage On Dianthus Therapeutics with Overweight Rating, Announces Price Target of $135

2026-03-12T20:01:00Z

GlobeNewswire
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

2026-03-12T15:06:20Z

Analyst Upgrades
Wedbush Maintains Outperform on Dianthus Therapeutics, Raises Price Target to $103

2026-03-10T12:24:45Z

Analyst Upgrades
Wedbush Maintains Outperform on Dianthus Therapeutics, Raises Price Target to $80

2026-03-10T12:10:28Z

Analyst Upgrades
Raymond James Upgrades Dianthus Therapeutics to Strong Buy, Raises Price Target to $123

2026-03-10T10:57:49Z

Analyst Upgrades
Baird Maintains Outperform on Dianthus Therapeutics, Raises Price Target to $132

2026-03-10T09:13:31Z

Analyst Upgrades
Clear Street Maintains Buy on Dianthus Therapeutics, Raises Price Target to $130

2026-03-09T20:01:00Z

GlobeNewswire
Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering